相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Host Restriction Factors Modulating HIV Latency and Replication in Macrophages
Isabel Pagani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Human APOBEC3 Variations and Viral Infection
Shiva Sadeghpour et al.
VIRUSES-BASEL (2021)
Why interventions to prevent intimate partner violence and HIV have failed young women in southern Africa
Jenevieve Mannell et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2019)
Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies
Nazanin Mohammadzadeh et al.
VIROLOGY (2019)
Hormonal influence on HIV-1 transmission in the female genital tract: New insights from systems biology
Haley A. Dupont et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2018)
Novel host restriction factors implicated in HIV-1 replication
Dibya Ghimire et al.
JOURNAL OF GENERAL VIROLOGY (2018)
Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia
Genet Gebrehiwet Hailu et al.
PLOS ONE (2018)
Host Restriction Factors and Human Immunodeficiency Virus (HIV-1): A Dynamic Interplay Involving All Phases of the Viral Life Cycle
Vanessa D'Urbano et al.
CURRENT HIV RESEARCH (2018)
Correlation of Apolipoprotein B mRNA-editing Enzyme, Catalytic Polypeptide-like 3G Genetic Variant rs8177832 with HIV-1 Predisposition in Pakistani Population
Khurshid Iqbal et al.
CURRENT HIV RESEARCH (2018)
Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1
Marta Colomer-Lluch et al.
FRONTIERS IN IMMUNOLOGY (2018)
Host genetic variation and HIV disease: from mapping to mechanism
Vivek Naranbhai et al.
IMMUNOGENETICS (2017)
Reassessing APOBEC3G Inhibition by HIV-1 Vif-Derived Peptides
Christopher M. Richards et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
CUL5 and APOBEC3G Polymorphisms are Partially Implicated in HIV-1 Infection and Antiretroviral Therapy in a Brazilian Population
Ronaldo Celerino da Silva et al.
CURRENT HIV RESEARCH (2017)
HIV-1 and hijacking of the host immune system: the current scenario
Muhammad Imran et al.
APMIS (2016)
HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso
Tegwinde Rebeca Compaore et al.
BMC INFECTIOUS DISEASES (2016)
APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso
Tegwinde Rebeca Compaore et al.
PLOS ONE (2016)
Correction for multiple testing in a gene region
Audrey E. Hendricks et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2014)
Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population
S. Ezzikouri et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Host factors and HIV-1 replication: clinical evidence and potential therapeutic approaches
Mariana Santa-Marta et al.
FRONTIERS IN IMMUNOLOGY (2013)
APOBEC3-Mediated Editing in HIV Type 1 from Pediatric Patients and Its Association with APOBEC3G/CUL5 Polymorphisms and Vif Variability
Federico A. De Maio et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
HIV-1 genome is often defective in PBMCs and rectal tissues after long-term HAART as a result of APOBEC3 editing and correlates with the size of reservoirs
Slim Fourati et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Restricting HIV the SAMHD1 way: through nucleotide starvation
Diana Ayinde et al.
NATURE REVIEWS MICROBIOLOGY (2012)
HIV-1 Subtype distribution in morocco based on national sentinel surveillance data 2004-2005
Mohammed Akrim et al.
AIDS RESEARCH AND THERAPY (2012)
Loci Polymorphisms of the APOBEC3G Gene in HIV Type 1-Infected Brazilians
Maria Clara Bizinoto et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2011)
Effect of HIV-1 Vif variability on progression to pediatric AIDS and its association with APOBEC3G and CUL5 polymorphisms
Federico A. De Maio et al.
INFECTION GENETICS AND EVOLUTION (2011)
Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India
Maria L. Ekstrand et al.
INTERNATIONAL HEALTH (2011)
APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load
Kavidha Reddy et al.
AIDS (2010)
APOBEC3G Generates Nonsense Mutations in Human T-Cell Leukemia Virus Type 1 Proviral Genomes In Vivo
Jun Fan et al.
JOURNAL OF VIROLOGY (2010)
HIV-I Vif, APOBEC, and intrinsic immunity
Ritu Goila-Gaur et al.
RETROVIROLOGY (2008)
APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts
Kate N. Bishop et al.
PLOS PATHOGENS (2008)
Absence of H186R polymorphism in Exon 4 of the APOBEC3G gene among North Indian individuals
Anurag Rathore et al.
GENETIC TESTING (2008)
Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: A possible role in the resistance to HIV of HIV-exposed seronegative individuals
Mara Biasin et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
SNPStats:: a web tool for the analysis of association studies
Xavier Sole et al.
BIOINFORMATICS (2006)
G→A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo
TL Kieffer et al.
JOURNAL OF VIROLOGY (2005)
Haploview: analysis and visualization of LD and haplotype maps
JC Barrett et al.
BIOINFORMATICS (2005)
Exhaustive genotyping of the CEM15 (APOBEC3G) gene and absence of association with AIDS progression in a French cohort
H Do et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Rapid evolution of primate antiviral enzyme APOBEC3G
JZ Zhang et al.
HUMAN MOLECULAR GENETICS (2004)
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
AM Sheehy et al.
NATURE (2002)
Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease
EL Murphy et al.
ANNALS OF INTERNAL MEDICINE (2001)